Menu

Iambic Therapeutics, Inc. IAM

Full chart Compare
Set alert

Price alert · IAM

All alert types
10.17 USD -1.47 (-12.63%)

At closeNov 6, 2026, 7:10 PM EST

10.41 +0.24 +2.41%

After hours · Nov 6, 7:10 PM ET

9.60 Day range 11.84
10.17 52-week range 23.81
YTD
-46.22%
1 year
-46.22%

Revenue & Expenses

Other Income → Expenses: $5.12MExpenses → Selling, General & Admin: $14.25MExpenses → Research & Development: $77.53MExpenses → Interest Expense: $17.00KExpenses → Income Tax: $45.00KGross Profit → Expenses: $9.43MRevenue → Gross Profit: $9.43MNet Loss → Expenses: $77.30MOther Income$5.12MGross Profit$9.43MNet Loss$77.30MExpenses$91.84MSelling, General & Admin$14.25MResearch & Development$77.53MInterest Expense$17.00KIncome Tax$45.00KRevenue$9.43M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

IAM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
9.43M1.19M
9.43M1.19M
9.43M1.19M
91.78M55.07M
77.53M45.70M
14.25M9.38M
-82.35M-53.88M
17.00K8.00K
45.00K34.00K
-77.30M-47.88M
-77.30M-47.88M
-77.30M-47.88M
-77.30M-47.88M
-3.57-2.23
-3.57-2.23
-3.57-2.23
-77.23M-47.84M
-77.23M-47.84M
21.62M21.42M
21.62M21.42M